QQ客服 官方微博 反馈留言

	Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein--based doxorubicin prodrug: in-vitro and in-vivo evaluation
	Huang, Sichao[1]; Zhang, Yuchen[3]; Zhong, Jinsong[1]; Pan, Ying[2]; Cai, Shaohui[3]; Xu, Jun[3]
	2018
卷号	29期号:3页码:253
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4617446
专题	暨南大学
作者单位	1.[1]Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Dept Pharm, Zhuhai, Peoples R China 2.[2]Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Dept Oncol, Zhuhai, Peoples R China 3.[3]Jinan Univ, Coll Pharm, Dept Clin Pharm, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Huang, Sichao[1],Zhang, Yuchen[3],Zhong, Jinsong[1],et al. Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein--based doxorubicin prodrug: in-vitro and in-vivo evaluation[J],2018,29(3):253.
APA	Huang, Sichao[1],Zhang, Yuchen[3],Zhong, Jinsong[1],Pan, Ying[2],Cai, Shaohui[3],&Xu, Jun[3].(2018).Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein--based doxorubicin prodrug: in-vitro and in-vivo evaluation.,29(3),253.
MLA	Huang, Sichao[1],et al."Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein--based doxorubicin prodrug: in-vitro and in-vivo evaluation".29.3(2018):253.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。